Pons PLM, de la Cruz de OA, Álvarez CI, Daudinot GY, Salomón LJ

Language: Spanish
References: 7
Page: 498-503
PDF size: 158.11 Kb.

ABSTRACT

A descriptive study was carried out in "Dr. Juan Bruno Zayas Alfonso" Teaching General Hospital in Santiago de Cuba, from September, 2010 to May, 2011, with the objective of showing the value of gadolinium to diagnose different diseases by means of the contrast and simple magnetic resonance. Female sex, age groups from16-25 and 26-35 years, brain and hypophysis tumors prevailed in the case material as the disorders which mostly needed the contrast, the slight enhancement of the lesion and the confirmation of the diagnosis subsequent to the administration of this contrast.

REFERENCES

1. Val MR, Kevin IN. Agentes de contraste. En: Stark David D. Resonancia magnética. 3 ed. Madrid: Harcourt/Elsevier; 2000.p. 257-8.

2. Nelson KL, Runge VM. Basic principles of MR contrast. Top Magn Reson Imaging. 1995; 7(3): 124-36.

3. Runge VM, Wells JW. Safety new applications, new MR agents. Top Magn Reson Imaging. 1995; 7(3): 181-95.

4. Principios básicos de resonancia magnética. [Internet] [citado 10 Jul 2011]. Disponible en: http://sirfreakthemighty.wikidot.com/mri:basics

5. Haughton VM, Rimm AA, Czervionke LF. Sensitivity of Gd- DTPA enhanced MR imaging of bening extraaxial tumors. Radiology. 1988; 166(3):829-33.

6. Healy ME, Hesselink JR, Press GA. Middleton MS. Increased detection of intracranial metastases with Gd- DTPA. Radiology. 1987; 165(3):619-24.

7. Kirsh JE. Basic principles of magnetic resonance contrast agents. Top Magn Reson Imaging. 1991;3(2):1-18.